I am a founder of RECEPTOR.AI, an innovative biotech company specialized in Artificial Intelligence drug discovery. The company mission is to create superior drugs, which are safe, efficient and successful in clinical trials by developing a next-generation drug discovery platform based on the synergy of AI, computational chemistry and biomimetic technologies, such as organs-on-a-chip.
I successfully ran two AI startups for B2B and have vast experience in automation and optimisation of business processes in big companies. I have proven to successfully build up and coach highly efficient teams, as well as to set and realise strategic plans of prospective expansive growth. Now, I am applying my expertise to implement the synergy of sophisticated AI technologies for breakthrough progress in biotech.
Contributing Author
Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.
